These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28284204)

  • 1. Calcium - Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug - Croton membranaceus Müll.Arg.
    Asare GA; Ngala RA; Afriyie D; Adjei S; Nyarko A; Anang-Quartey Y; Asiedu B; Doku D; Amoah BY; Bentum K; Musah I; Mossanda K
    BMC Complement Altern Med; 2017 Mar; 17(1):152. PubMed ID: 28284204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of benign prostatic hyperplasia with Croton membranaceus in an experimental animal model.
    Afriyie DK; Asare GA; Bugyei K; Adjei S; Lin JM; Peng J; Hong ZF
    J Ethnopharmacol; 2014 Nov; 157():90-8. PubMed ID: 25256687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific targeting of the aqueous root extract of Croton membranaceus in experimental animals.
    Afriyie DK; Asare GA; Bugyei K; Asiedu-Gyekye IJ; Tackie R; Adjei S
    Andrologia; 2014 Sep; 46(7):753-60. PubMed ID: 23957252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-dependent apoptogenic activity of the aqueous root extract of Croton membranaceus against human BPH-1 cells.
    Afriyie DK; Asare GA; Bugyei K; Lin J; Peng J; Hong Z
    Genet Mol Res; 2015 Jan; 14(1):149-62. PubMed ID: 25729946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxicity studies of Croton membranaceus root extract.
    Asare GA; Sittie A; Bugyei K; Gyan BA; Adjei S; Addo P; Wiredu EK; Nyarko AK; Otu-Nyarko LS; Adjei DN
    J Ethnopharmacol; 2011 Apr; 134(3):938-43. PubMed ID: 21335084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.
    Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ
    J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP;
    Prog Urol; 2002 Jun; 12(3):384-92; discussion 394-4. PubMed ID: 12189744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment.
    Suardi N; Gandaglia G; Nini A; Montorsi F; Pellucchi F; Agostini A; Rigatti P
    Minerva Urol Nefrol; 2014 Jun; 66(2):119-25. PubMed ID: 24988203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients.
    Asare GA; Anang Y; Afriyie DK; Amoah BY; Asiedu B; Doku D; Ocansey HS; Odei Danso NY; Tekpor P; Osam S
    Medicines (Basel); 2017 Nov; 4(4):. PubMed ID: 29156544
    [No Abstract]   [Full Text] [Related]  

  • 11. Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract.
    Asare GA; Afriyie D; Ngala RA; Appiah AA; Anang Y; Musah I; Adjei S; Bamfo-Quaicoe K; Sule D; Gyan BA; Arhin P; Edoh DA
    Evid Based Complement Alternat Med; 2015; 2015():365205. PubMed ID: 26106434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    Elterman DS; Lawrentschuk N; Guns E; Hersey K; Adomat H; Wood CA; Fleshner N
    J Urol; 2010 May; 183(5):2085-9. PubMed ID: 20303529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Echinacea purpurea (L.) Moench extract on experimental prostate hyperplasia.
    Skaudickas D; Kondrotas AJ; Kevelaitis E; Venskutonis PR
    Phytother Res; 2009 Oct; 23(10):1474-8. PubMed ID: 19288499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP
    Eur Urol; 2002 May; 41(5):497-506; discussion 506-7. PubMed ID: 12074791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
    Keetch DW; Andriole GL; Ratliff TL; Catalona WJ
    Urology; 1997 Dec; 50(6):901-5. PubMed ID: 9426721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of lignan extract from flax hulls on experimentally induced benign prostate hyperplasia.
    Bisson JF; Hidalgo S; Simons R; Verbruggen M
    J Med Food; 2014 Jun; 17(6):650-6. PubMed ID: 24460407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.
    Safarinejad MR
    J Herb Pharmacother; 2005; 5(4):1-11. PubMed ID: 16635963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.
    Fujimoto K; Hirao Y; Masumori N; Arai Y; Yamanaka H; Kato T; Miyazawa K
    Int J Urol; 2006 May; 13(5):543-9. PubMed ID: 16771723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.